This inventor holds 1 USPTO granted patent and 4 published patent applications and 1 EPO patent. Top assignee: Ucb Holdings, Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Nanqun Zhu - Innovator in Neurological and Inflammatory Disease Treatments
Introduction
Nanqun Zhu is an accomplished inventor based in Lexington, MA (US). He is currently associated with Ra Pharmaceuticals, Inc., where he focuses on developing innovative treatments for neurological and inflammatory diseases. Despite having no granted patents to his name, his contributions to the field are noteworthy.
Latest Patent Applications
Nanqun Zhu has been involved in several significant patent applications. One of his latest applications is titled "Neurological Disease Treatment with Zilucoplan." This application outlines methods for treating myasthenia gravis, including generalized myasthenia gravis, through the use of C5 complement inhibitors. The application also includes devices and kits for administering these inhibitors and methods for evaluating the efficacy of the treatment. Another important application is "Inflammatory Disease Treatment with Complement Inhibitors." This disclosure provides methods for treating inflammatory conditions using complement inhibitor compounds and compositions. It specifically addresses neuromuscular inflammatory indications, such as Immune-Mediated Necrotizing Myopathy.
Conclusion
Nanqun Zhu's work at Ra Pharmaceuticals, Inc. highlights his commitment to advancing medical treatments for complex diseases. His innovative approaches in the field of complement inhibitors demonstrate the potential for significant advancements in patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile